2025-2031年CAR-T疗法市场规模、份额及预测
CAR-T Therapy Market Report Analysis
CAR-T Therapy Market
-
CAGR (2025 - 2031)16.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis International AG
- Kite Pharma, Inc. (Gilead Sciences, Inc.)
- Juno Therapeutics (Celgene Corporation)
- Bluebird Bio, Inc. (Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc
- Aurora Biopharma Inc.
- Legend Biotech (Genscript Biotech Corporation)
- Pfizer, Inc.
Regional Overview
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Market Segmentation
By 靶抗原
- CD 19
- BCMA
- HER2
- GD2
- CD 20
- CD22
- CD30
- CD33
- HER1 等
By 治疗应用
- 急性淋巴细胞白血病
- 慢性淋巴细胞白血病
- 弥漫大B细胞淋巴瘤
- 滤泡性淋巴瘤
- 多发性骨髓瘤
- 胶质母细胞瘤
- 肉瘤
- 神经母细胞瘤
- 急性髓系白血病
- 乳腺癌
- 胰腺癌
- 肝细胞癌
- 结直肠癌等
By 地理
- 北美洲
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Get Free Sample For